Original Research: Biomarker Testing in a Canadian Centre for Patients with Non‑small Cell Lung Cancer: Assessing Residual Risks. Canadian Oncology Today, [S. l.], v. 2, n. 3, p. 22–28, 2025. DOI: 10.58931/cot.2025.2342. Disponível em: https://canadianoncologytoday.com/article/view/2-3-Liu_et_al. Acesso em: 6 apr. 2026.